芬太尼透皮貼用于子宮腺肌癥的鎮(zhèn)痛療效觀察
發(fā)布時間:2018-03-27 15:51
本文選題:子宮腺肌癥 切入點:痛經 出處:《中日友好醫(yī)院學報》2016年06期
【摘要】:目的:觀察芬太尼透皮貼用于子宮腺肌癥患者經期的鎮(zhèn)痛效果。方法:將48例以嚴重痛經為主要臨床癥狀的子宮腺肌癥患者隨機分為治療組和對照組,前者采用芬太尼透皮貼鎮(zhèn)痛;后者使用芬必得,均于月經來潮前3d開始用藥至月經d3,共治療3個月經周期。采用視覺模擬評分(VAS)法評價鎮(zhèn)痛效果,同時記錄治療副反應。結果:2種方法對于子宮腺肌癥重度痛經患者均有明顯效果,但治療組患者每療程后VAS評分均較對照組低;且隨著療程增加,對照組鎮(zhèn)痛效果逐漸減弱,治療組鎮(zhèn)痛效果無減退。結論:芬太尼透皮貼可以有效緩解子宮腺肌癥患者痛經癥狀,簡便易行,無明顯不良反應,適合臨床推廣。
[Abstract]:Objective: To observe the analgesic effect of transdermal fentanyl for menstruating women with adenomyosis. Methods: 48 cases with severe dysmenorrhea were the main symptoms of the patients with adenomyosis were randomly divided into treatment group and control group, the former transdermal analgesia with fentanyl; the latter were using Fenbid, before menstruation began to 3D use D3 to menstruation, were treated for 3 menstrual cycles. Using visual analogue scale (VAS) method to evaluate the analgesic effect and side effects of the therapy and recorded. Results: 2 methods for adenomyosis dysmenorrhea patients had obvious effect, but the treatment group patients with VAS score after each course of treatment was lower than the control group; and with the the control group treatment increased the analgesic effect gradually weakened, the analgesic effect of the treatment group was not decreased. Conclusion: transdermal fentanyl can effectively alleviate the symptoms of dysmenorrhea in patients with adenomyosis, simple, no obvious adverse reaction, suitable for clinical Guangzhou.
【作者單位】: 河北北方學院附屬第二醫(yī)院婦產科;中日友好醫(yī)院婦產科;
【分類號】:R711.71
【相似文獻】
相關期刊論文 前10條
1 林琬君,張娜;子宮腺肌癥374例臨床分析[J];武警醫(yī)學院學報;2002年03期
2 王曉華,閆冰冰,李云峰;子宮腺肌癥300例臨床分析[J];第四軍醫(yī)大學學報;2004年20期
3 Koga K.;Osuga Y.;Hiroi H.;張e,
本文編號:1672189
本文鏈接:http://sikaile.net/yixuelunwen/fuchankeerkelunwen/1672189.html
最近更新
教材專著